Skip to content

C91.12

Billable

Chronic lymphocytic leukemia of B-cell type in relapse

HCC Category Mapping

V28HCC 22Colorectal, Bladder, and Other Cancers
0.000
V24HCC 10Lymphoma and Other Cancers
0.675
ESRDHCC 10Lymphoma and Other Cancers
0.000
RxHCCHCC 19Lymphoma and Other Cancers
0.000

What This Code Means

A type of blood cancer (chronic lymphocytic leukemia) that started in B-cells and has returned after initial treatment.

Coding Tips

  • The fifth character '2' indicates relapse status - ensure documentation clearly states the cancer has returned after remission
  • This code is specific to B-cell type CLL; verify cell type is documented before coding

Clinical Significance

Chronic lymphocytic leukemia of B-cell type in relapse indicates that a previously treated and remission-achieving CLL has returned with detectable disease activity. Relapsed CLL often requires a change in treatment strategy and may indicate development of resistance to prior therapy. Relapsed disease frequently behaves more aggressively and may carry adverse cytogenetic changes acquired during treatment.

Documentation Requirements

  • Documentation must confirm both a prior period of remission and current evidence of disease recurrence, including rising lymphocyte counts, progressive lymphadenopathy, or bone marrow re-infiltration.
  • The date of relapse, interval since last remission, and prior treatment regimens should be documented.
  • Updated cytogenetic and molecular testing (including TP53 mutation and del(17p) status) should be noted.

Commonly Confused Codes

Code Hierarchy

Open C91.12 in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.